Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...
Wash., found procedures in the state that were previously approved in two weeks now take four to eight weeks to be authorized ...
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...
The law would amend the Social Security Act, which governs both Medicare and Medicaid.
Medicare Part B costs will rise in 2026. Here's what to expect, including higher prescription drug prices and payment changes ...
We’re going to demystify the process by providing a clear signal to device manufacturers of exactly what targets they need to ...
The law would require Medicare Part D plans to include lower‑cost generics when they are cheaper than brand‑name drugs.
The federal government scrapped a plan to have health insurance companies fund coverage of obesity drugs for seniors, opting ...
A delay in a Medicare pilot to cover obesity drugs due to health insurers' hesitation to participate in the program is ...
New legislation aims to make post-acute care services more accessible and streamline prior authorization approval in Medicare ...
The pathway is designed to reduce the delay between FDA authorization and Medicare coverage for certain Class II and Class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results